#United States #New York #Levi & Korsinsky #Securities Fraud #Geron Corporation

Levi & Korsinsky Announces Class Action Against Geron Corporation

April 18, 2025 – Levi & Korsinsky, LLP has notified investors of Geron Corporation (NASDAQ: GERN) regarding a class action securities lawsuit being filed. This lawsuit comes in light of alleged securities fraud directed at Geron and its investors, which transpired between February 28, 2024, and February 25, 2025.

CLASS DEFINITION

The essence of the lawsuit is to seek reparations for investors whose financial positions were negatively impacted by the purported fraud committed by Geron during the specified period. It serves as a crucial step for investors affected to potentially recover their losses.

CASE DETAILS

The complaint scrutinizes Geron's management for failing to disclose vital information that could have influenced the investors' understanding of the company's projected growth. Central to the allegations is Rytelo (imetelstat), a drug that Geron positioned as a promising treatment. The lawsuit outlines that the defendants from Geron projected confidence in the efficacy, demand, and market potential of Rytelo, despite minimizing risks associated with its required monitoring and competitive landscape.

Critical events occurred on February 26, 2025, when Geron released its financial results for the fourth quarter of fiscal 2024. It reported a disappointing flattening of Rytelo's growth, attributing it to seasonal factors, competition, public awareness issues, and the stringent monitoring necessary for prescribing the drug. This news triggered a plummeting of Geron's stock price from a closing market value of $2.37 per share on February 25 to $1.61 per share just a day later, illustrating a staggering drop of approximately 32.07%.

WHAT'S NEXT?

Investors who suffered losses during the timeline mentioned are urged to act quickly as they have until May 12, 2025, to petition the Court for the designation of lead plaintiff. It’s important to note that participation as a lead plaintiff is not necessary to share in any potential financial recovery from the lawsuit, lowering the threshold for all affected parties.

NO COST TO YOU

Notably, for those classified as class members, there is no cost or obligation to participate in the lawsuit. Compensation may be available without the need for any out-of-pocket expenditures, making this a risk-free opportunity for eligible investors.

WHY LEVI & KORSINSKY?

For two decades, Levi & Korsinsky has been dedicated to advocating for shareholders, achieving substantial financial reparations for those wronged in complex securities matters. With a professional team boasting over 70 members, they have earned their place among the top securities litigation law firms in the United States. Their consistent ranking in ISS Securities Class Action Services' Top 50 Report for seven consecutive years further solidifies their reputation.

CONTACT INFORMATION

Investors seeking further information or who are interested in participating in the lawsuit can reach out to:
Joseph E. Levi, Esq.
Email: [email protected]
Telephone: (212) 363-7500
Levi & Korsinsky, LLP
33 Whitehall Street, 17th Floor
New York, NY 10004

For more details and to submit claims, please visit their website.

This class action could be pivotal for Geron investors looking to recover from significant losses attributed to alleged misinformation and mismanagement during a crucial operational period.